Status:
ENROLLING_BY_INVITATION
Automated Clinical Pathway for Inflammatory Bowel Disease Care
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
Pragmatic randomized controlled trial to evaluate the effect of an electronic medical record-based tool on improving on-time follow up and its effects on inflammatory bowel disease outcomes
Eligibility Criteria
Inclusion
- Alive patients with 2 or more visits to the UT Southwestern adult digestive disease clinic within 3 years of the date of trial commencement including at least one visit within 2 years, and
- An active inflammatory bowel disease-specific medication, and
- At least one of the following:
- Inflammatory bowel disease on the active problem list
- An inflammatory bowel disease invoice diagnosis at least twice in the 3 years prior to trial commencement
- An inflammatory bowel disease encounter diagnosis at least twice in the 3 years prior to trial commencement
Exclusion
- Patients not meeting inclusion criteria
Key Trial Info
Start Date :
December 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 13 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07167836
Start Date
December 12 2025
End Date
December 13 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern
Dallas, Texas, United States, 75390